吉列德科学和美CDC就HIV事先预防(PrEP)药的专利归属首次互撕在公堂!美CDC于2019就起诉吉列德科学没支付PrEP的2个口服药专利费,GILD对此说法坚决予以否认;CDC科学家在新的千禧第一个10年发现,2种抗艾药emtricitabine和tenofovir组合在一起,可高效预防HIV感染;吉列德科学的Truvada和Descovy均含emtricitabine/tenofovir,202...
PrEP 是一种新的为HIV阴性的人群设计的药。每天一颗,一周到两周后开始奏效。每天吃这个药可以使HIV阴性的人跟阳性的人有性接触也不会感染,99%的保护率。美国FDA已经批准两年多了并且鼓励HIV高危人群持续服用。中国似乎还知名度不是很高。现在应该还在医药公司的专利期内所以价格不低,但是专利期过后有望降低。相关...
因为多次服用阻断药又不规律,感觉像是在prep和pep之间的状态,如果严格的话按prep,全网又找不到明确说多久可以排除的,只找英国标准中提到停止prep后45天这么一句话,但是他的依据是美国英国cdc标准中,99百分位在暴露后45天内可以检出来定的但是严格讲缺少一个数据!就是prep后停药的人和未prep人,两者99分位最长检出...
The article offers information on the report released by the U.S. Centers for Disease Control & Prevention on July 13, 2011 regarding the use of antiretroviral drugs with Truvada brand as pre-exposure prophylaxis...
HIV testing venues The potential impact of PrEP implementation at CDC-funded nonclinical HIV testing venuesThe potential impact of PrEP implementation at CDC-funded nonclinical HIV testing venuesVanessa M Kung
『科普』♀12-19..You can get or transmit HIV only through specific activities. Most commonly, people get or transmit
"While a vaccine or cure may one day end the HIV epidemic, PrEP is a powerful tool that has the potential to alter the course of the U.S. HIV epidemic today," Dr. Jonathan Mermin, director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, said in the...
Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States used to estimate the percentage of infections averted (PIA) and the number needed to treat (NNT) under behavioral indications of the CDC's PrEP ... SM Jenne...
前面两期我们熟悉了HIV暴露前预防(PrEP)理念及公共卫生意义,中国暴露前预防用药专家共识;本期我们将通过全球几项以舒发泰®(恩曲他滨/替诺福韦片,FTC/TDF)作为PrEP的重要临床研究,一起探讨开展HIV暴露前预防的有效性、安全性、对性行...
近日,美国食品药品监督管理局(FDA)批准ViiV Healthcare研发的长效注射针剂卡博特韦(cabotegravir,英文商品名Apretude),用于体重≥35公斤(77磅)的高风险成人和青少年进行HIV暴露前预防(PrEP)。这是全球首款无需每日服药的长效PrEP方案。 PrEP的重大突破 HIV...